Results 31 to 40 of about 577,333 (195)

Clinical significance of anti-DFS70 in immunoinflammatory rheumatic diseases (review)

open access: yesНаучно-практическая ревматология, 2023
The relevance of the problem of immunoinflammatory rheumatic diseases (IIRD) for modern medicine is determined by their high prevalence in the population, the difficulty of early diagnosis, the rapid development of disability and poor life prognosis ...
T. A. Panafidina   +4 more
doaj   +1 more source

Nonsystemic vasculitic neuropathy

open access: yesMedical Journal of Dr. D.Y. Patil Vidyapeeth, 2020
A 21-year-old female born of nonconsanguineous marriage presented with gradually progressive quadriplegia for 3 years. Weakness was distal more than proximal, with wasting. She also had moderate pain in extremities.
Shalesh Rohatgi   +2 more
doaj   +1 more source

Intracellular and circulating neuronal antinuclear antibodies in human epilepsy

open access: yesNeurobiology of Disease, 2013
There are overwhelming data supporting the inflammatory origin of some epilepsies (e.g., Rasmussen's encephalitis and limbic encephalitis). Inflammatory epilepsies with an autoimmune component are characterized by autoantibodies against membrane-bound ...
Philip H. Iffland, II   +8 more
doaj   +1 more source

Antinuclear Antibodies: A demographic profile from a Tertiary Healthcare Centre of Delhi

open access: yesSVU - International Journal of Medical Sciences, 2023
Background: Anti-nuclear autoantibodies (ANA), have explicitly been linked to immune complex-mediated autoimmune diseases. Detection and quantitation of autoantibodies are therefore crucial in the diagnosis and treatment.
Krishna Sarkar   +3 more
doaj   +1 more source

Lupus-like nephritis with positive anti-neutrophil cytoplasmic antibodies and negative antinuclear antibodies

open access: yesBrazilian Journal of Nephrology, 2020
Antineutrophil cytoplasmic antibodies (ANCAs) are associated with small vessel vasculitis but their prevalence is not rare in other immune diseases.
Joana Eugénio Santos   +6 more
doaj   +2 more sources

Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?

open access: yesTurkish Journal of Hematology, 2022
Objective: Eltrombopag remains a prominent option in the treatment of steroid-dependent or steroid-refractory immune thrombocytopenia (ITP) patients. Unfortunately, not all patients respond to eltrombopag.
Mehmet Baysal   +4 more
doaj   +1 more source

Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited

open access: yesDiagnostic Pathology, 2009
It has been more than 50 years since antinuclear antibodies were first discovered and found to be associated with connective tissue diseases. Since then different methods have been described and used for their detection or confirmation.
Minz Ranjana   +2 more
doaj   +1 more source

Antinuclear antibodies

open access: yesAutoimmunity, 2005
The presence of abnormal levels of autoantibodies to intracellular antigens is a hallmark of systemic connective tissue disease. The indirect immunofluorescence assay is the most commonly used routine test for the detection of antinuclear antibodies.
openaire   +2 more sources

Immunology markers that can be predictive for the diagnosis of juvenile idiopathic arthritis

open access: yesJournal of Laboratory Medicine, 2020
This study aimed to investigate the implications of antinuclear antibodies (ANAs) in juvenile idiopathic arthritis (JIA), the association with uveitis and the favorable evolution of the disease.
Sur Lucia M.   +9 more
doaj   +1 more source

Antinuclear antibodies in systemic sclerosis associated with increased risk of malignancy

open access: yesPrzegląd Dermatologiczny, 2018
Patients with systemic sclerosis are at 1.5–5-fold increased risk of developing malignant diseases. It has been shown that some types of antinuclear antibodies associated with systemic sclerosis may have predictive value for development of malignant ...
Anna Stochmal   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy